Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion type Assertion NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_head.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion evidence source_evidence_literature NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion SIO_000772 10688044 NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion wasDerivedFrom befree-2016 NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.
- NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_assertion wasGeneratedBy ECO_0000203 NP276008.RAvUAe7ydWwkyetwTS9Td1GxIv6Qwl9fNSUOioOD9YFYI130_provenance.